Market Updates on Stock Ratings

Wall Street has recently seen a variety of notable research adjustments that could affect investor decisions. Here’s a roundup of today’s key findings for those keeping a close eye on the market.

Top 5 Upgrades:

• Northland has upgraded Palantir (PLTR), raising the price target from $185 to $190 following what they described as “excellent results” in the fourth quarter. The aim is to outperform the market.

• Daiwa has upgraded Visa (V) from Neutral to Outperform, keeping the target at $370. They adjusted their earnings expectations in light of the company’s first-quarter results released on January 29 and made a “slight upward revision” to their medium-term outlook. Additionally, they upgraded Mastercard (MA) from Neutral to Outperform, increasing the price target from $605 to $610.

• Morgan Stanley is changing their rating for Affirm (AFRM) from equal weight to overweight, but the target price will drop from $83 to $76. According to a research note, recent share price drops present “compelling risks and rewards.”

• City has moved JetBlue (JBLU) from Sell to Neutral, upping the price target from $4 to $6. They see “upside risk” in the stock price and suggest that JetBlue could potentially be a strategic option among airlines.

• DA Davidson has upgraded Q2 Holdings (QTWO) from Neutral to Buy, maintaining the target price at $82. Although there’s uncertainty about their future fourth-quarter outcomes, they believe a decline in stock prices over the past several months has created a more appealing entry point.

Top 5 Downgrades:

• Piper Sandler has downgraded Adobe (ADBE). Following a change in analyst coverage, the price target has been cut from $470 to $330, changing the rating from Overweight to Neutral. Concerns have been raised about sheet compression and vibe coding potentially capping the company’s multiples, but they stressed that this is not a definitive judgment on the fourth-quarter earnings.

• RBC Capital has downgraded Elevance Health (ELV) from Outperform to Sector Perform, lowering the price target from $392 to $358. While management is “encouraged” by confidence in underlying performance, they remain cautious due to weaker-than-expected guidance for 2026 and future earnings.

• BofA has downgraded Shape (FIGR), adjusting the price target from $43 to $42 and the rating from Neutral to Underperform. They pointed out that although its stock has jumped 109% in the five months since the IPO, Coinbase (COIN) has seen a significant decline, leading them to label the valuation gap as “too wide.”

• BNP Paribas has downgraded Exxon Mobil (XOM), after dropping the price target range from $114 to $125, moving the rating from Neutral to Underperform. They cited the company’s price-to-earnings ratio as the highest it’s been in five years.

• Roth Capital downgraded Cotera Energy (CTRA), cutting the price target from $30 to $28 and changing the rating from Buy to Neutral. Despite a “somewhat disappointing” takeaway price, they don’t foresee receiving a higher offer than competitors like Devon Energy (DVN).